In the news
The vaccine alternatives for people with compromised immune systems
As the COVID-19 vaccine rollout gathers pace, a population is at risk of being left behind: the millions of people… Read More »The vaccine alternatives for people with compromised immune systems
EMA reviewing data on four COVID monoclonal antibodies
The European Medicines Agency (EMA) on Thursday announced its Committee for Medicinal Products for Human Use (CHMP) is reviewing data… Read More »EMA reviewing data on four COVID monoclonal antibodies
Monoclonal Antibody for Patients with Covid-19
However, we previously measured transudation of human immunodeficiency virus type 1 (HIV-1) monoclonal antibodies (VRC07-523 and PGT121) into tissues of… Read More »Monoclonal Antibody for Patients with Covid-19
Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection
By the end of 2020, more than 19 million Americans had received the diagnosis of severe acute respiratory syndrome coronavirus… Read More »Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection
Monoclonal Antibodies: Developers Explore New Territories
The idea that antibodies could serve as therapeutics emerged over 100 years ago. Nevertheless, antibody therapeutics have taken a long… Read More »Monoclonal Antibodies: Developers Explore New Territories